This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa

Scott Boyd, M.D, Ph.D.
Associate Professor at Stanford University Medical Center

Profile

Dr. Boyd is a physician scientist and Associate Professor in the Department of Pathology at Stanford University. The Boyd laboratory uses serological analysis, DNA sequencing, single-cell experiments and other tools to study the B cells that make antibodies in human immune responses to infection and vaccination, as well as in immunological disorders such as food allergy and immunodeficiency.


Many of the laboratory’s projects study the complex genes that encode antibodies, and the way that these genes form the basis of immunological memory in health and disease. His laboratory, together with colleagues at Stanford and other institutions, currently has a major new focus in studying the antibody and B cell responses to SARS-CoV-2 infection, to understand whether antibodies affect the severity of COVID-19 disease in patients, to evaluate whether infected or vaccinated people will develop protective immunity, and if so, to assess how long immunity will last. He is the Principal Investigator of the NIH-supported Stanford SARS-CoV-2 Serological Science Center of Excellence, for research into COVID-19.


Dr. Boyd received bachelor's degrees in Biochemistry at the University of Manitoba, and English Literature at Oxford University, where he was a Rhodes Scholar. He obtained his M.D. from Harvard Medical School and Ph.D. from MIT, followed by pathology residency, a hematopathology fellowship, and postdoctoral research work at Stanford University. He is a 2019 recipient of the Presidential Early Career Award for Scientists and Engineers, and was elected to the American Society for Clinical Investigation in 2020.

Agenda Sessions

  • B cell Repertoire and Serological Responses to SARS-CoV-2

    On Demand
  • Sourcing Disease-specific Human Antibodies from Patient Repertoires

    10:15am